When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. That said, here is one stock poised to prove Wall Street wrong and two facing legitimate challenges.
Two Stocks to Sell:
W.W. Grainger (GWW)
Consensus Price Target: $1,292 (-4.7% implied return)
Founded as a supplier of motors, W.W. Grainger (NYSE: GWW) provides maintenance, repair, and operating (MRO) supplies and services to businesses and institutions.
Why Does GWW Fall Short?
- Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 5.1% over the last two years was below our standards for the industrials sector
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Earnings per share lagged its peers over the last two years as they only grew by 1.3% annually
W.W. Grainger is trading at $1,356 per share, or 29.1x forward P/E. To fully understand why you should be careful with GWW, check out our full research report (it’s free).
United Bankshares (UBSI)
Consensus Price Target: $50 (3.4% implied return)
With roots dating back to 1982 and a strong presence in the Mid-Atlantic region, United Bankshares (NASDAQ: UBSI) is a bank holding company that provides commercial and retail banking services through its United Bank subsidiary across multiple states.
Why Do We Avoid UBSI?
- Muted 8.5% annual net interest income growth over the last five years shows its demand lagged behind its banking peers
- Estimated net interest income growth of 4% for the next 12 months implies demand will slow from its five-year trend
- Earnings growth over the last five years fell short of the peer group average as its EPS only increased by 3.2% annually
At $48.37 per share, United Bankshares trades at 1.2x forward P/B. Read our free research report to see why you should think twice about including UBSI in your portfolio.
One Stock to Buy:
Incyte (INCY)
Consensus Price Target: $122.86 (0.1% implied return)
Founded in 1991 and evolving from a genomics research firm to a commercial-stage drug developer, Incyte (NASDAQ: INCY) is a biopharmaceutical company that discovers, develops, and commercializes proprietary therapeutics for cancer and inflammatory diseases.
Why Should You Buy INCY?
- Annual revenue growth of 22.8% over the past two years was outstanding, reflecting market share gains this cycle
- Free cash flow margin increased by 12.5 percentage points over the last five years, giving the company more capital to invest or return to shareholders
- Rising returns on capital show management is finding more attractive investment opportunities
Incyte’s stock price of $122.74 implies a valuation ratio of 54.1x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
